サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1799134

ヘルスケアCMOの世界市場

Healthcare CMO

出版日
ページ情報
英文 174 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.25円
ヘルスケアCMOの世界市場
出版日: 2025年08月27日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 174 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ヘルスケアCMOの世界市場は2030年までに2,911億米ドルに達する見込み

2024年に1,587億米ドルと推定されるヘルスケアCMOの世界市場は、2024年から2030年にかけてCAGR 10.6%で成長し、2030年には2,911億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである医薬品CMOは、CAGR 9.3%を記録し、分析期間終了時には1,850億米ドルに達すると予測されます。医療機器CMOセグメントの成長率は、分析期間中CAGR13.2%と推定されます。

米国市場は432億米ドルと推定、中国はCAGR14.2％で成長予測

米国のヘルスケアCMO市場は、2024年に432億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに592億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは14.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ7.8%と9.3%と予測されています。欧州では、ドイツがCAGR約8.3%で成長すると予測されています。

世界のヘルスケアCMO市場- 主要動向と促進要因まとめ

製造受託機関はなぜヘルスケアのサプライチェーンに不可欠になりつつあるのか？

ヘルスケア製造受託機関（CMO）は、医薬品、医療機器、生物製剤の製造サービスをアウトソーシングしています。これらの組織は、製剤化、製造から包装、流通に至るまで、複雑な業務を扱っています。ヘルスケア企業がコスト削減、市場投入までの時間短縮、規制遵守の維持というプレッシャーに直面する中、CMOは生産戦略においてますます中心的な役割を果たすようになってきています。

CMOは、ヘルスケアブランドのオーナーが資本集約的なインフラ投資をすることなく、専門施設や技術的専門知識を利用することができます。これは、ニッチな治療法や医療技術を開発する中小企業にとって特に価値があります。大企業もまた、CMOを活用して製造の柔軟性を高め、需要急増に対応し、現地生産能力で新市場に参入しています。

CMOは医薬品と医療技術の分野でどのように能力を拡大しているか？

医薬品CMOは、高力価医薬品製造、無菌注射剤、連続製造の能力を強化しています。モノクローナル抗体や細胞療法を含む生物製剤製造では、上流および下流の処理能力に多額の投資が行われています。CMOは、充填仕上げサービス、コールドチェーンロジスティクス、繊細な製剤のための先進パッケージングを拡大しています。

医療機器分野では、CMOは精密金型、積層造形、自動化を取り入れ、外科用機器、診断用機器、ウェアラブル機器の厳しい要件に対応しています。電子部品の統合、滅菌サービス、品質文書化などは、国際的な規制の枠組みに準拠するために拡張されている重要な能力です。多くのCMOは現在、設計支援から規制当局への申請、市販後のサポートまで、エンドツーエンドのサービスを提供しており、製品ライフサイクル管理における役割を強化しています。

CMOの需要はどこで高まり、どの治療分野がアウトソーシング活動をリードしているか？

CMOサービスに対する需要は北米、欧州、アジア太平洋で高まっているが、サービスの専門性や重点治療分野には地域差があります。がん、自己免疫疾患、希少疾患は、複雑な製造ニーズと標的治療モデルにより、医薬品のアウトソーシングを推進する主要分野です。医療機器では、診断、低侵襲手術、コネクテッド・ヘルス・ソリューションの需要が最も高いです。

社内のインフラが限られているバイオテクノロジー企業は、臨床試験材料と商業規模の生産の両方でCMOへの依存を強めています。既存の製薬会社は、社内のリソースを最適化するため、成熟した製品ラインを低コストの地域のCMOにアウトソーシングしています。診断薬の分野では、CMOが世界ヘルスの需要に応え、アッセイキット、試薬、機器コンポーネントの迅速なスケールアップをサポートしています。このようなパターンは、臨床と商業のサプライチェーン全体でCMOの関連性を強めています。

ヘルスケアCMO市場の成長の原動力は？

ヘルスケアCMO市場の成長は、製造の専門化、治療の複雑性、サプライチェーンの最適化に関連するいくつかの要因によってもたらされます。生物製剤、無菌注射剤、個別化医薬品の開発増加は、専門的なインフラを持つ受託製造業者の利用を促しています。自動化、コンプライアンス・システム、高スループット生産の進歩は、業務効率と規制との整合性を向上させています。また、利益率の低いレガシー製品のアウトソーシングの増加、バーチャルバイオ企業の参入、世界の医薬品パイプラインの拡大も成長を支えています。ヘルスケア企業がよりスリムなオペレーションと技術的なスケールアップを追求する中、CMOは医薬品と医療機器にまたがる重要な生産パートナーになりつつあります。

セグメント

タイプ（医薬品CMO、医療機器CMO）

調査対象企業の例

  • Almac Group
  • AMRI（Albany Molecular Research Inc.）
  • Boehringer Ingelheim BioXcellence
  • Catalent, Inc.
  • CordenPharma International GmbH
  • Emergent BioSolutions Inc.
  • Famar Health Care Services
  • Fareva Group
  • Grifols International S.A.
  • Jubilant Pharmova Ltd.
  • Lonza Group AG
  • Patheon（by Thermo Fisher Scientific）
  • PCI Pharma Services
  • Pfizer CentreOne
  • Piramal Pharma Solutions
  • Recipharm AB
  • Samsung Biologics
  • Siegfried Holding AG
  • Thermo Fisher Scientific Inc.
  • Wuxi AppTec

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP38895

Global Healthcare CMO Market to Reach US$291.1 Billion by 2030

The global market for Healthcare CMO estimated at US$158.7 Billion in the year 2024, is expected to reach US$291.1 Billion by 2030, growing at a CAGR of 10.6% over the analysis period 2024-2030. Pharmaceutical CMO, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$185.0 Billion by the end of the analysis period. Growth in the Medical Device CMO segment is estimated at 13.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$43.2 Billion While China is Forecast to Grow at 14.2% CAGR

The Healthcare CMO market in the U.S. is estimated at US$43.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$59.2 Billion by the year 2030 trailing a CAGR of 14.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.8% and 9.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.

Global Healthcare CMO Market - Key Trends & Drivers Summarized

Why Are Contract Manufacturing Organizations Becoming Integral to Healthcare Supply Chains?

Healthcare Contract Manufacturing Organizations (CMOs) provide outsourced manufacturing services for pharmaceutical products, medical devices, and biologics. These organizations handle complex tasks ranging from formulation and production to packaging and distribution. As healthcare companies face pressure to reduce costs, accelerate time-to-market, and maintain regulatory compliance, CMOs are playing an increasingly central role in production strategies.

CMOs offer access to specialized facilities and technical expertise without requiring capital-intensive infrastructure investments by the healthcare brand owner. This is particularly valuable for small and mid-sized firms developing niche therapies or medical technologies. Larger companies are also leveraging CMOs to increase manufacturing flexibility, manage demand surges, and enter new markets with local production capabilities.

How Are CMOs Expanding Capabilities Across Pharmaceuticals and Medtech?

Pharmaceutical CMOs are enhancing capabilities in high-potency drug production, sterile injectables, and continuous manufacturing. Biologics manufacturing, including monoclonal antibodies and cell therapies, is seeing significant investment in upstream and downstream processing capacity. CMOs are expanding fill-finish services, cold chain logistics, and advanced packaging for sensitive formulations.

In the medical device sector, CMOs are incorporating precision tooling, additive manufacturing, and automation to meet the stringent requirements of surgical, diagnostic, and wearable devices. Electronic component integration, sterilization services, and quality documentation are critical capabilities being scaled up for compliance with international regulatory frameworks. Many CMOs now offer end-to-end services from design assistance to regulatory submissions and post-market support, consolidating their role in product lifecycle management.

Where Is CMO Demand Rising and Which Therapeutic Areas Lead Outsourcing Activity?

Demand for CMO services is rising in North America, Europe, and Asia-Pacific, with regional differences in service specialization and therapeutic focus. Oncology, autoimmune diseases, and rare conditions are key areas driving pharmaceutical outsourcing due to complex manufacturing needs and targeted treatment models. For medical devices, demand is strongest in diagnostics, minimally invasive surgery, and connected health solutions.

Biotech firms with limited in-house infrastructure are increasingly relying on CMOs for both clinical trial materials and commercial-scale production. Established pharma companies are outsourcing mature product lines to CMOs in lower-cost regions to optimize internal resources. In diagnostics, CMOs are supporting rapid scaling of assay kits, reagents, and instrument components in response to global health demands. These patterns are reinforcing CMO relevance across clinical and commercial supply chains.

What Is Driving Growth in the Healthcare CMO Market?

Growth in the healthcare CMO market is driven by several factors related to manufacturing specialization, therapeutic complexity, and supply chain optimization. Rising development of biologics, sterile injectables, and personalized medicines is encouraging use of contract manufacturers with specialized infrastructure. Advances in automation, compliance systems, and high-throughput production are improving operational efficiency and regulatory alignment. Growth is also supported by increased outsourcing of low-margin legacy products, entry of virtual biotech companies, and expansion of global pharmaceutical pipelines. As healthcare firms seek leaner operations and technical scale-up, CMOs are becoming critical production partners across drugs and devices.

SCOPE OF STUDY:

The report analyzes the Healthcare CMO market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Pharmaceutical CMO, Medical Device CMO)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Almac Group
  • AMRI (Albany Molecular Research Inc.)
  • Boehringer Ingelheim BioXcellence
  • Catalent, Inc.
  • CordenPharma International GmbH
  • Emergent BioSolutions Inc.
  • Famar Health Care Services
  • Fareva Group
  • Grifols International S.A.
  • Jubilant Pharmova Ltd.
  • Lonza Group AG
  • Patheon (by Thermo Fisher Scientific)
  • PCI Pharma Services
  • Pfizer CentreOne
  • Piramal Pharma Solutions
  • Recipharm AB
  • Samsung Biologics
  • Siegfried Holding AG
  • Thermo Fisher Scientific Inc.
  • Wuxi AppTec

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Healthcare CMO - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Outsourced Pharmaceutical and Medical Device Manufacturing Drives Growth in Healthcare CMOs
    • Surge in Biologics and Complex Drug Formulations Spurs Demand for Specialized CMO Capabilities in Aseptic and High-Potency Manufacturing
    • Expansion of Small and Virtual Biotech Companies Strengthens Business Case for End-to-End CMO Partnerships
    • Growing Regulatory Complexity Across Global Markets Encourages Reliance on CMOs With Compliance and QA Expertise
    • Increased Focus on Cost Optimization and Time-to-Market Pressures Propel Demand for Flexible, Scalable CMO Services
    • Expanding CDMO (Contract Development and Manufacturing Organization) Models Combine R&D With Scalable Production
    • Growth in Personalized Medicine and Orphan Drug Development Generates Opportunities for Niche and Adaptive CMOs
    • Rising Demand for Fill-Finish, Packaging, and Serialization Services Strengthens CMO Role in Final Drug Product Delivery
    • Technological Advancements in Continuous Manufacturing and PAT Tools Enhance Efficiency and Traceability in CMO Processes
    • Rising Adoption of Subscription-Based and Pay-Per-Use Models Makes Fitness Clubs More Accessible to Price-Sensitive Consumers
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Healthcare CMO Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Healthcare CMO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Healthcare CMO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Healthcare CMO by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Pharmaceutical CMO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Pharmaceutical CMO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Pharmaceutical CMO by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Medical Device CMO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Medical Device CMO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Medical Device CMO by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: USA 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: Canada 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • JAPAN
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: Japan 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • CHINA
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: China 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • EUROPE
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Healthcare CMO by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Healthcare CMO by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: Europe 16-Year Perspective for Healthcare CMO by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • FRANCE
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: France 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • GERMANY
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Germany 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Italy 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: UK 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Spain 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Russia 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare CMO by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Healthcare CMO by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for Healthcare CMO by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 56: Australia Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Australia 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • INDIA
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 59: India Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: India Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: India 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: South Korea 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for Healthcare CMO by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for Healthcare CMO by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Latin America 16-Year Perspective for Healthcare CMO by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Argentina 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Brazil 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Mexico 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Rest of Latin America 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for Healthcare CMO by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for Healthcare CMO by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Middle East 16-Year Perspective for Healthcare CMO by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 92: Iran Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Iran Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Iran 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 95: Israel Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Israel Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Israel 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Saudi Arabia Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Saudi Arabia 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 101: UAE Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UAE Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: UAE 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Middle East Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Rest of Middle East 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030
  • AFRICA
    • Healthcare CMO Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 107: Africa Recent Past, Current & Future Analysis for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Africa Historic Review for Healthcare CMO by Type - Pharmaceutical CMO and Medical Device CMO Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Africa 16-Year Perspective for Healthcare CMO by Type - Percentage Breakdown of Value Sales for Pharmaceutical CMO and Medical Device CMO for the Years 2014, 2025 & 2030

IV. COMPETITION